N. Varol
Impact in
-
- Diabetes Management and Research
- Diabetes Treatment and Management
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
-
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 14
- Cancer Immunotherapy and Biomarkers 11
- Lung Cancer Research Studies 4
-
- Lung Cancer Treatments and Mutations 10
- Lung Cancer Diagnosis and Treatment 5
- Co-authors
- Sarah Goring (7 shared papers)Kristina S. Boye (3 shared papers)Frank Griesinger (1 shared paper)Sheena Kayaniyil (1 shared paper)Phil McEwan (2 shared papers)Ellen Korol (1 shared paper)James L. Palmer (2 shared papers)V. Foos (4 shared papers)
- Journals
- Value in Health (9 papers)Lung Cancer (3 papers)Journal of Medical Economics (3 papers)Journal of Thoracic Oncology (2 papers)Annals of Oncology (2 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
N. Varol
23 papers receiving 288 citations
Peers
Comparison fields: 5 of 60
- Endocrinology, Diabetes and Metabolism 137
- Oncology 89
- Pulmonary and Respiratory Medicine 76
- Family Practice 4
- Cancer Research 22
Countries citing papers authored by N. Varol
This map shows the geographic impact of N. Varol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Varol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Varol more than expected).
Fields of papers citing papers by N. Varol
This network shows the impact of papers produced by N. Varol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Varol. The network helps show where N. Varol may publish in the future.
Co-authors
The 25 scholars most cited alongside N. Varol, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 99 | |
| 2 | 2019 | 88 | |
| 3 | 2014 | 40 | |
| 4 | 2023 | 15 | |
| 5 | 2023 | 7 | |
| 6 | 2022 | 7 | |
| 7 | 2018 | 6 | |
| 8 | 2022 | 6 | |
| 9 | 2022 | 5 | |
| 10 | 2022 | 5 | |
| 11 | 2013 | 3 | |
| 12 | 2014 | 2 | |
| 13 | 2023 | 1 | |
| 14 | 2021 | 1 | |
| 15 | 2012 | 1 | |
| 16 | 2020 | 1 | |
| 17 | 2021 | 1 | |
| 18 | 2020 | 1 | |
| 19 | 2021 | 1 | |
| 20 | 2013 | 1 |
About N. Varol
N. Varol is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Economics and Econometrics, Endocrinology, Diabetes and Metabolism and Surgery, having authored 26 papers that have together received 294 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (11 papers), Lung Cancer Treatments and Mutations (10 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers), Diabetes Treatment and Management (6 papers), Lung Cancer Diagnosis and Treatment (5 papers), Diabetes Management and Research (5 papers), Economic and Financial Impacts of Cancer (5 papers) and Lung Cancer Research Studies (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (137 citations), Oncology (89 citations), Pulmonary and Respiratory Medicine (76 citations), Family Practice (4 citations) and Cancer Research (22 citations). N. Varol has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Sarah Goring, Kristina S. Boye, Frank Griesinger, Sheena Kayaniyil, Phil McEwan, Ellen Korol, James L. Palmer, V. Foos, David Grant and Bradley Curtis. Their work appears in journals such as Value in Health, Lung Cancer, Journal of Medical Economics, Journal of Thoracic Oncology and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.